- Home
- ALZN vs SSY Comparison
ALZN vs SSY Comparison
Compare ALZN & SSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALZN
- SSY
- Stock Information
- Founded
- ALZN 2016
- SSY 1959
- Country
- ALZN United States
- SSY United States
- Employees
- ALZN N/A
- SSY N/A
- Industry
- ALZN Medicinal Chemicals and Botanical Products
- SSY Hospital/Nursing Management
- Sector
- ALZN Health Care
- SSY Health Care
- Exchange
- ALZN Nasdaq
- SSY Nasdaq
- Market Cap
- ALZN 6.1M
- SSY 5.5M
- IPO Year
- ALZN 2021
- SSY N/A
- Fundamental
- Price
- ALZN $1.00
- SSY $1.02
- Analyst Decision
- ALZN Strong Buy
- SSY
- Analyst Count
- ALZN 1
- SSY 0
- Target Price
- ALZN $20.00
- SSY N/A
- AVG Volume (30 Days)
- ALZN 210.7K
- SSY 44.2K
- Earning Date
- ALZN 03-10-2025
- SSY 05-14-2025
- Dividend Yield
- ALZN N/A
- SSY N/A
- EPS Growth
- ALZN N/A
- SSY N/A
- EPS
- ALZN N/A
- SSY 0.14
- Revenue
- ALZN N/A
- SSY $31,233,000.00
- Revenue This Year
- ALZN $322.64
- SSY N/A
- Revenue Next Year
- ALZN N/A
- SSY N/A
- P/E Ratio
- ALZN N/A
- SSY $7.18
- Revenue Growth
- ALZN N/A
- SSY N/A
- 52 Week Low
- ALZN $0.64
- SSY $0.53
- 52 Week High
- ALZN $15.06
- SSY $1.91
- Technical
- Relative Strength Index (RSI)
- ALZN 51.86
- SSY 50.55
- Support Level
- ALZN $0.95
- SSY $0.97
- Resistance Level
- ALZN $1.13
- SSY $1.10
- Average True Range (ATR)
- ALZN 0.09
- SSY 0.10
- MACD
- ALZN 0.02
- SSY 0.00
- Stochastic Oscillator
- ALZN 65.13
- SSY 61.54
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
About SSY SunLink Health Systems Inc.
SunLink Health Systems Inc is engaged in providing retail pharmacy services. The company operates its business through segments namely the Healthcare Services segment and Pharmacy segment. The Healthcare Services segment includes subsidiaries that own and operate licensed-bed, acute care hospitals, which includes bed geriatric psychology unit, and nursing home; own medical buildings, which are leased to unaffiliated healthcare providers, and adjacent vacant land; and provides information technology to outside customers. The Pharmacy segment, which is the key revenue generator is composed of retail pharmacy products and services that are conducted in rural markets; institutional pharmacy services; pharmacy services; and durable medical equipment.